Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
about
Cannabis and psychosis/schizophrenia: human studiesMarijuana and cannabinoid regulation of brain reward circuitsGone to Pot - A Review of the Association between Cannabis and PsychosisGenetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.Cannabinoids and psychosisModulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in HumansDopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamideThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisPrevious exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.Differential effects of dopamine D2 and GABA(A) receptor antagonists on dopamine neurons between the anterior and posterior ventral tegmental area of female Wistar ratsAbnormal cerebellar morphometry in abstinent adolescent marijuana usersEffects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate.Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers.Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?Cannabidiol for the treatment of psychosis in Parkinson's disease.Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse ForebrainChronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamateNeurobiological processes in adolescent addictive disorders.The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects.Treating prolactinoma and psychosis: medication and cognitive behavioural therapy.D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.Anhedonia and substance dependence: clinical correlates and treatment options.Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels.Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.Effects of THC on behavioral measures of impulsivity in humans.The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.Medial prefrontal cannabinoid CB1 receptors modulate consolidation and extinction of cocaine-associated memory in mice.Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.Subjective effects of cannabis before the first psychotic episode.
P2860
Q24628837-47528261-455D-4CDB-9BD5-2D99E9F0AC77Q24671514-B573A109-C6C4-4473-834F-30A530293056Q26865311-5FB88742-6EE0-4A8F-9A19-C8B9BB22C3ABQ27315226-D1B384D6-0496-470A-A302-30D5B9FE1F45Q28241328-4DF13898-6AAC-4879-9E0E-909F6CFB9665Q28533998-9C46035E-60C9-4DEB-888D-FE6C6DEA6E32Q28972550-D4CC854C-21B2-41E3-B253-A704728089DCQ30047193-85C2D7CC-275A-451D-83C8-70CBAD436056Q30500429-130E81A1-A11A-4DE8-94D2-56EABB8B5E45Q33809619-57698AEF-7B8E-40A8-8889-A53A5A964E23Q33838292-02BD00D1-3506-4C0E-A800-8397EBC63485Q33886277-A6C898D9-B097-4528-B10C-FD1A3D1056DEQ34103173-A3C7F8CE-6458-40D6-B497-B571110B6381Q34273699-2C29851B-2197-439A-B9E2-29EC131E297AQ34477182-50A58C4A-3CE7-4E88-94A7-0B5079C47A35Q34676610-9D93FB5C-A78B-4862-A41F-88CC8B1BA8ABQ34830827-5AC2B6F5-0C97-4241-B96A-D4B075F1C598Q35962060-85A0918F-8945-467D-89CD-0C833DC28EA5Q35982298-61E3216D-89D3-4ACF-A14D-401074066DC5Q36358712-3C9A6992-1CD4-471B-ABE8-6FCEAA722F78Q36508688-7430F01A-51E4-43F9-A8A0-976236F50DA7Q36965847-A9A5A1B2-769D-4B56-A99B-886A56D1FEE2Q37015433-0AA49092-9C1F-4554-ACFA-4BC2F3DC4D2AQ37310301-D2205997-2DF8-4203-87F9-DA30D525E660Q37329121-BCCEFA73-F816-4A3A-A653-883396F9824AQ37341421-38F0C113-441A-4896-855F-7CDF3E106DE2Q39799846-1632935F-7D72-40CD-9835-C8D58D323E0FQ41833761-5D523EF5-AD49-44ED-9719-2010D6C4DF22Q42728896-8D6ABFBF-4A45-4434-93A9-6BD4D5CB2212Q43760360-13BB91C0-5781-4E55-BCAA-379140D8D52AQ43815277-C1005998-04DD-4A8E-B81D-D2E77C14E9E1Q43975380-733024DD-59A0-4A4B-B7CF-4FD0BCF858D2Q44464153-EC9851F0-6A66-43F3-ADA2-8D9570334B76Q45174910-2F4AEB43-C3CC-47FA-9562-BE668CFC6D86Q46715759-2CDBAF26-94F4-48B8-BEF1-9A72951744EFQ47787266-82EEA9FD-A959-4714-95BD-8CEE487887B0Q47930409-A642465D-7945-45FD-B8AE-6374ACC1F5F2Q50716534-64D74968-4460-49AB-9889-1F62BF59E60A
P2860
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@en
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@nl
type
label
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@en
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@nl
prefLabel
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@en
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@nl
P2860
P921
P1476
Increase in meso-prefrontal do ...... CB1 receptors by cannabinoids.
@en
P2093
P2860
P304
P356
10.1111/J.1460-9568.1998.00292.X
P407
P50
P577
1998-09-01T00:00:00Z